Shannon M Farley
Overview
Explore the profile of Shannon M Farley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
SARS-CoV-2 transmission dynamics in Mozambique and Zimbabwe during the first 3 years of the pandemic
Kaondera-Shava R, Galanti M, Perini M, Suh J, Farley S, Chicumbe S, et al.
R Soc Open Sci
. 2025 Jan;
12(1):241275.
PMID: 39845719
The 2019 emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its rapid spread created a public health emergency of international concern. However, the impact of the pandemic in...
2.
Farahani M, Farley S, Smart T, Ndagije F, Maile L, Longwe H, et al.
Lancet HIV
. 2024 Dec;
12(1):e51-e59.
PMID: 39672185
Background: Lesotho has made substantial efforts to control its HIV epidemic. We aimed to assess progress towards UNAIDS 95-95-95 targets in Lesotho by comparing data from the Lesotho Population-based HIV...
3.
Conderino S, Thorpe L, Divers J, Albrecht S, Farley S, Lee D, et al.
BMJ Public Health
. 2024 Nov;
2(2).
PMID: 39568629
Introduction: There is growing interest in using electronic health records (EHRs) for chronic disease surveillance. However, these data are convenience samples of in-care individuals, which are not representative of target...
4.
Greenleaf A, Francis S, Zou J, Farley S, Lekhela T, Asiimwe F, et al.
JMIR Public Health Surveill
. 2024 Oct;
10:e55208.
PMID: 39378443
Background: Participatory surveillance involves at-risk populations reporting their symptoms using technology. In Lesotho, a landlocked country of 2 million people in Southern Africa, laboratory and case-based COVID-19 surveillance systems were...
5.
Conderino S, Anthopolos R, Albrecht S, Farley S, Divers J, Titus A, et al.
JMIR Med Inform
. 2024 Oct;
12:e58085.
PMID: 39353204
Background: Electronic health records (EHRs) are increasingly used for epidemiologic research to advance public health practice. However, key variables are susceptible to missing data or misclassification within EHRs, including demographic...
6.
Metz M, Among V, Dzinamarira T, Ussery F, Nkurunziza P, Bahizi J, et al.
Trop Med Infect Dis
. 2024 Sep;
9(9).
PMID: 39330909
During population-based HIV impact assessments (PHIAs), some participants who self-reported testing HIV-positive (PSRP) tested negative in one or more subsequent survey HIV tests. These unexpected discrepancies between their self-reported results...
7.
Francis S, Mwima G, Lethoko M, Chang C, Farley S, Asiimwe F, et al.
BMC Infect Dis
. 2023 Oct;
23(1):688.
PMID: 37845641
Background: While laboratory testing for infectious diseases such as COVID-19 is the surveillance gold standard, it is not always feasible, particularly in settings where resources are scarce. In the small...
8.
Sisti J, Prasad D, Niederman S, Mezzacca T, Anekwe A, Clapp J, et al.
PLoS One
. 2023 May;
18(5):e0274648.
PMID: 37134045
In 2016, New York City (NYC) began enforcing a sodium warning regulation at chain restaurants, requiring placement of an icon next to any menu item containing ≥2,300 mg sodium. As...
9.
Prasad D, Jasek J, Anekwe A, Dominianni C, Mezzacca T, Sisti J, et al.
PLoS One
. 2023 Apr;
18(4):e0274044.
PMID: 37093825
In 2016, New York City (NYC) began enforcing a sodium warning regulation at chain restaurants, requiring placement of an icon next to any menu item containing ≥2,300 mg sodium. As...
10.
Farley S, Wang C, Bray R, Low A, Delgado S, Hoos D, et al.
J Int AIDS Soc
. 2022 Sep;
25 Suppl 4:e26005.
PMID: 36176030
Introduction: Achieving optimal HIV outcomes, as measured by global 90-90-90 targets, that is awareness of HIV-positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among...